Palatin Technologies
PTN
#9856
Rank
โ‚น3.97 B
Marketcap
โ‚น2,337
Share price
-8.18%
Change (1 day)
3,219.71%
Change (1 year)

Revenue for Palatin Technologies (PTN)

Revenue in 2025 (TTM): โ‚น0.78 Billion

According to Palatin Technologies's latest financial reports the company's current revenue (TTM ) is โ‚น0.80 Billion. In 2024 the company made a revenue of โ‚น30.02 Million a decrease over the revenue in the year 2023 that were of โ‚น0.59 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Palatin Technologies from 1998 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น0.78 B2517.87%
2024 โ‚น30.02 M-94.92%
2023 โ‚น0.59 B147.68%
2022 โ‚น0.23 B329.9%
2021 โ‚น55.49 M-267.67%
2020 -โ‚น33.1 Million-100.77%
2019 โ‚น4.30 B107.94%
2018 โ‚น2.07 B-60.58%
2017 โ‚น5.25 B
2016 N/A
2015 N/A-100%
2014 โ‚น0.82 B
2013 N/A-100%
2012 โ‚น2.48 M-81.64%
2011 โ‚น13.53 M-93.28%
2010 โ‚น0.20 B-78.66%
2009 โ‚น0.94 B426.51%
2008 โ‚น0.17 B-70.44%
2007 โ‚น0.60 B-26.78%
2006 โ‚น0.82 B0.1%
2005 โ‚น0.82 B101.14%
2004 โ‚น0.41 B256.04%
2003 โ‚น0.11 B128.32%
2002 โ‚น50.59 M166.65%
2001 โ‚น18.97 M-89.52%
2000 โ‚น0.18 B45.55%
1999 โ‚น0.12 B265.51%
1998 โ‚น34.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
MediciNova
MNOV
โ‚น23.44 M-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น243.81 B 30,221.39%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น75.14 B 9,245.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น22.83 B 2,739.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚น17.52 B 2,079.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.374 T 1,041,419.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
โ‚น36.19 B 4,401.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น5.282 T 656,884.14%๐Ÿ‡ฌ๐Ÿ‡ง UK